Overview
Neurópixel Therapeutics develops minimally invasive, light-based neuromodulation implants that use optogenetic stimulation to treat refractory epilepsy and chronic pain.
More in Neuromodulation
Latest industry news
Aurenar Raises $5.7M to Accelerate Stroke Neuromodulation Device Development
2026-09-21 · Funding
UCANACT Raises €800,000 to Advance Brain-Computer Communication Technology
2026-09-20 · Funding
Tether Evo Takes On One of BCI's Hardest Engineering Problems
2026-09-19 · Research
Neuroprosthesis Breakthrough Enables Paralyzed Patients to Speak and Move Simultaneously
2026-09-18 · Research
Company details
Category
⚡ Neuromodulation
Location
San Diego, CA
Funding
Series A — $22M
Website
neurópixeltherapeutics.comListed
2026-09-21
Is this your company?
Claim this listing to add your logo, full description, team, and products. Premium listings get featured placement.
Claim & upgrade listingAdvertise
Reach neurotech professionals
Newsletter sponsorships, featured listings, and sponsored articles.
View packages →